drugset / Trial / NCT05816707

The Assessment of Curcuma Longa Potentials for Soft and Hard Tissue Healing in Fresh

NCT05816707

Phase 1 Completed 30 enrolled Rania Farouk Mohamed Abdulmaguid
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will be conducted on 30 patients with split mouth design patients will be divided into curcumin and PRF groups patients will have bilateral tooth extraction one side will receive curcumin/PRF and the other side will be control soft tissue healing and bone quality will be evaluated post-operative

Timeline

Start
2024-05-01
Primary completion
2026-02-01
Completion
2026-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator PRF Unknown
Comparator curcuma longa Unknown

Indications

No indication recorded.